title: Flavonoid regulation of EAG1 channels.
abstract: The voltage-gated, K(+)-selective ether á go-go 1 (EAG1) channel is expressed throughout the brain where it is thought to regulate neuronal excitability. Besides its normal physiological role in the brain, EAG1 is abnormally expressed in several cancer cell types and promotes tumor progression. Like all other channels in the KCNH family, EAG1 channels have a large intracellular carboxy-terminal region that shares structural similarity with cyclic nucleotide-binding homology domains (CNBHDs). EAG1 channels, however, are not regulated by the direct binding of cyclic nucleotides and have no known endogenous ligands. In a screen of biological metabolites, we have now identified four flavonoids as potentiators of EAG1 channels: fisetin, quercetin, luteolin, and kaempferol. These four flavonoids shifted the voltage dependence of activation toward more hyperpolarizing potentials and slowed channel deactivation. All four flavonoids regulated channel gating with half-maximal concentrations of 2-8 µM. The potentiation of gating did not require the amino-terminal or post-CNBHD regions of EAG1 channels. However, in fluorescence resonance energy transfer and anisotropy-based binding assays, flavonoids bound to the purified CNBHD of EAG1 channels. The CNBHD of KCNH channels contains an intrinsic ligand, a conserved stretch of residues that occupy the cyclic nucleotide-binding pocket. Mutations of the intrinsic ligand in EAG1 (Y699A) potentiated gating similar to flavonoids, and flavonoids did not further potentiate EAG1-Y699A channels. Furthermore, the Y699A mutant CNBHD bound to flavonoids with higher affinity than wild-type CNBHD. These results suggest that the flavonoids identified here potentiated EAG1 channels by binding to the CNBHD, possibly by displacing their intrinsic ligand. EAG1 channels should be considered as a possible target for the physiological effects of flavonoids.
authors: Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195, USA.
authors: Anne E
authors: AE
authors: Carlson
authors: Tinatin I
authors: TI
authors: Brelidze
authors: William N
authors: WN
authors: Zagotta
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000235:genetics; D000818:Animals; D051638:Ether-A-Go-Go Potassium Channels / Q000235:genetics* / Q000378:metabolism*; D005419:Flavonoids / Q000494:pharmacology*; D044948:Flavonols; D015640:Ion Channel Gating / Q000187:drug effects* / Q000235:genetics; D044949:Kaempferols / Q000494:pharmacology; D008024:Ligands; D047311:Luteolin / Q000494:pharmacology; D051379:Mice; D009154:Mutation; D009712:Nucleotides, Cyclic / Q000235:genetics / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011794:Quercetin / Q000494:pharmacology; D014982:Xenopus laevis
chemical_list: D051638:Ether-A-Go-Go Potassium Channels; D005419:Flavonoids; D044948:Flavonols; D044949:Kaempferols; D008024:Ligands; D009712:Nucleotides, Cyclic; C006552:kaempferol; D011794:Quercetin; D047311:Luteolin; C017875:fisetin